S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
The "Smart Money" Is Ready for May 1st Are You? (Ad)
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Abbott Laboratories Outlook is Healthy: Buy the Dip
Top 5 AI Stocks to Buy for 2024 (Ad)
Closing prices for crude oil, gold and other commodities
Stock market today: World shares are mixed after a tech-led retreat on Wall Street
The “Perfect Storm” for Gold (Ad)
Prologis Stock Leading U.S. Logistics Boom
Predicting a Bear Market: 7 Signs and Why it's Tough to Do
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
The "Smart Money" Is Ready for May 1st Are You? (Ad)
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Abbott Laboratories Outlook is Healthy: Buy the Dip
Top 5 AI Stocks to Buy for 2024 (Ad)
Closing prices for crude oil, gold and other commodities
Stock market today: World shares are mixed after a tech-led retreat on Wall Street
The “Perfect Storm” for Gold (Ad)
Prologis Stock Leading U.S. Logistics Boom
Predicting a Bear Market: 7 Signs and Why it's Tough to Do
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
The "Smart Money" Is Ready for May 1st Are You? (Ad)
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Abbott Laboratories Outlook is Healthy: Buy the Dip
Top 5 AI Stocks to Buy for 2024 (Ad)
Closing prices for crude oil, gold and other commodities
Stock market today: World shares are mixed after a tech-led retreat on Wall Street
The “Perfect Storm” for Gold (Ad)
Prologis Stock Leading U.S. Logistics Boom
Predicting a Bear Market: 7 Signs and Why it's Tough to Do
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
The "Smart Money" Is Ready for May 1st Are You? (Ad)
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Abbott Laboratories Outlook is Healthy: Buy the Dip
Top 5 AI Stocks to Buy for 2024 (Ad)
Closing prices for crude oil, gold and other commodities
Stock market today: World shares are mixed after a tech-led retreat on Wall Street
The “Perfect Storm” for Gold (Ad)
Prologis Stock Leading U.S. Logistics Boom
Predicting a Bear Market: 7 Signs and Why it's Tough to Do
Free Trial
NASDAQ:EUCR

Eucrates Biomedical Acquisition (EUCR) Stock Price, News & Analysis

→ Could Bitcoin Literally FORCE This Crypto To Rocket Up? (From Paradigm Press) (Ad)
Free EUCR Stock Alerts
Notice: This company has been marked as potentially delisted and may not be actively trading.
Compare
Today's Range
$10.02
▼
$10.04
50-Day Range
$10.04
▼
$10.25
52-Week Range
$9.87
▼
$10.25
Volume
12,700 shs
Average Volume
2,287 shs
Market Capitalization
$42.27 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Stock Analysis
Stock Analysis
EUCR stock logo

About Eucrates Biomedical Acquisition Stock (NASDAQ:EUCR)

Eucrates Biomedical Acquisition Corp. does not have significant operations. The company intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. It focuses to identify and acquire a business in the biomedical or healthcare-related industries in North America and Europe. The company was incorporated in 2020 and is based in New York, New York.

EUCR Stock News Headlines

February 1, 2024 | msn.com
Psyence Biomedical Finalizes Strategic Merger Agreement
November 28, 2023 | msn.com
What's Going On With Emergent Biosolutions Stock?
April 18, 2024 | Market Moving Trends (Ad)
Top 5 AI Stocks to Buy for 2024
5 Best AI Stocks to Invest In Investors are getting very rich in AI stocks right now. Wall Street legend is giving away the name and ticker of the little-known AI stock Wall Street is currently buying hand-over-fist.
September 15, 2023 | finanznachrichten.de
Mineralys Therapeutics, Inc.: Mineralys Therapeutics Expands its Board of Directors with Appointments of Glenn Sblendorio and Daphne Karydas
February 18, 2023 | marketwatch.com
8-K: Eucrates Biomedical Acquisition Corp.
February 18, 2023 | msn.com
Ocean Biomedical stock falls 26%, down 60% since SPAC merger
February 16, 2023 | marketwatch.com
Ocean Biomedical Debuts on Nasdaq, Shares Trading 11% Lower
February 8, 2023 | marketwatch.com
Global Implantable Biomaterial Market Analysis 2023 by Manufacture, Industry Competition Analysis, Revenue and Forecast to 2028
April 18, 2024 | Market Moving Trends (Ad)
Top 5 AI Stocks to Buy for 2024
5 Best AI Stocks to Invest In Investors are getting very rich in AI stocks right now. Wall Street legend is giving away the name and ticker of the little-known AI stock Wall Street is currently buying hand-over-fist.
February 6, 2023 | yahoo.com
Aesther and Ocean Biomedical Announce Shareholder Approval of Business Combination
February 3, 2023 | marketwatch.com
2023 Biomedical Materials Market (New) Research Revenue to Drive Integrate and Take Over Strategies to Expand Market Share to 2027
January 12, 2023 | finance.yahoo.com
Texas Biomed at forefront of Sudan ebolavirus biomedical R&D
July 12, 2022 | finance.yahoo.com
RealSeq Biosciences Selected in Top 14 Life Sciences Companies for the 2022 BioTools Innovator Accelerator
June 1, 2022 | benzinga.com
Bened Biomedical Acquires US Distributor Oryx...
March 25, 2022 | wsj.com
Reviva Pharmaceuticals Holdings Inc.
November 7, 2021 | nasdaq.com
Do Institutions Own Eucrates Biomedical Acquisition Corp. (NASDAQ:EUCR) Shares?
November 7, 2021 | finance.yahoo.com
What You Need To Know About Eucrates Biomedical Acquisition Corp.'s (NASDAQ:EUCR) Investor Composition
October 25, 2021 | finance.yahoo.com
Flare Therapeutics Appoints Daphne Karydas as COO and CFO, and Michaela Bowden, PhD, as SVP of Biology and Translation
August 18, 2021 | barrons.com
Eucrates Biomedical Acquisition Corp.
July 28, 2021 | thestreet.com
AdTheorent Going Public with MCAP Acquisition (MACQ)
See More Headlines
Receive EUCR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Eucrates Biomedical Acquisition and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Today
4/17/2024
Fiscal Year End
12/31/2024
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Unclassified
Industry
Holding & other investment offices
Sub-Industry
N/A
Current Symbol
NASDAQ:EUCR
CUSIP
N/A
CIK
1822929
Web
N/A
Phone
212-710-5220
Fax
N/A
Employees
4
Year Founded
N/A

Profitability

EPS (Most Recent Fiscal Year)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$2.42 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-62.82%
Return on Assets
2.95%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
2.03
Quick Ratio
2.03

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
$0.81 per share
Price / Cash Flow
12.36
Book Value
($1.25) per share
Price / Book
-8.03

Miscellaneous

Outstanding Shares
4,210,000
Free Float
3,386,000
Market Cap
$42.27 million
Optionable
Not Optionable
Beta
-0.07
These 7 Stocks Will Be Magnificent in 2024 Cover
These 7 Stocks Will Be Magnificent in 2024

With average gains of 150% since the start of 2023, now is the time to give these stocks a look and pump up your 2024 portfolio.

Get This Free Report

Key Executives

  • Mr. Parag Phoolchand Saxena MBA (Age 66)
    MS, CEO & Director
  • Dr. Evangelos Vergetis (Age 41)
    Pres, COO & Director
  • Mr. Gonzalo Cordova CFA (Age 67)
    Chief Financial Officer
  • Mr. Shrikant Sathe (Age 66)
    Sr. VP

Key Competitors

View All Competitors

This page (NASDAQ:EUCR) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners
He Is Giving Away Bitcoin
Crypto Swap Profits
[Urgent!] Generational Wealth Gameplan
Crypto 101 Media
Top 5 AI Stocks to Buy for 2024
Market Moving Trends
Top 5 Tech Stocks to Buy for 2024
Daily Market Alerts
Biden out June 13; Kamala won’t replace him?
Paradigm Press
Urgent alert: open this for a huge profit potential
Timothy Sykes
Options trading has suddenly become more reliable.
Eagle Publishing
The Greatest Bull Market in Crypto History…
Weiss Ratings